Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Theravance Biopharma

In Seth Klarman's portfolio · Baupost Group

Ticker TBPH

Not in the portfolio as of Q3 2026. Every quarter it shows up in a Baupost Group 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q3 2024 Sell 0  
Q2 2024 Reduce 36% 4,200,021 1.0% $8.48 $35.6M
Q1 2024 Reduce 11% 6,594,126 1.6% $8.97 $59.1M
Q4 2023 No change 7,419,226 1.8% $11.24 $83.4M
Q3 2023 No change 7,419,226 1.2% $8.63 $64.0M
Q2 2023 Reduce 29% 7,419,226 1.4% $10.35 $76.8M
Q1 2023 Reduce 9% 10,419,226 1.9% $10.85 $113.0M
Q4 2022 Reduce 15% 11,419,226 2.1% $11.22 $128.1M
Q3 2022 No change 13,419,226 2.3% $10.14 $136.1M
Q3 2022 Sell 0  
Q2 2022 Reduce 2% 13,419,226 1.8% $9.06 $121.6M
Q2 2022 Reduce 6% 28,104,000 0.4% $25.9M
Q1 2022 No change 13,643,333 1.4% $9.56 $130.4M
Q1 2022 No change 30,000,000 0.3% $28.6M
Q4 2021 No change 13,660,168 1.5% $11.05 $150.9M
Q4 2021 No change 30,000,000 0.3% $28.8M
Q3 2021 Add 38% 13,660,168 0.9% $7.40 $101.1M
Q3 2021 No change 30,000,000 0.3% $27.6M
Q2 2021 Add 13% 9,910,168 1.2% $14.52 $143.9M
Q2 2021 No change 30,000,000 0.2% $28.6M
Q1 2021 No change 8,735,168 1.4% $20.41 $178.3M
Q1 2021 No change 30,000,000 0.2% $30.6M
Q4 2020 No change 8,735,168 1.4% $17.77 $155.2M
Q4 2020 No change 30,000,000 0.3% $28.4M
Q3 2020 Reduce 6% 8,735,168 1.4% $14.78 $129.1M
Q3 2020 No change 30,000,000 0.3% $26.3M
Q2 2020 No change 9,309,168 2.4% $20.99 $195.4M
Q2 2020 No change 30,000,000 0.4% $29.2M
Q1 2020 No change 9,309,168 3.2% $23.11 $215.1M
Q1 2020 No change 30,000,000 0.4% $28.7M
Q4 2019 No change 9,309,168 2.7% $25.89 $241.0M
Q4 2019 No change 30,000,000 0.3% $31.1M
Q3 2019 No change 9,309,168 2.1% $19.48 $181.3M
Q3 2019 No change 30,000,000 0.3% $27.7M
Q2 2019 No change 9,309,168 1.4% $16.33 $152.0M
Q2 2019 No change 30,000,000 0.2% $25.7M
Q1 2019 No change 9,309,168 1.8% $22.67 $211.0M
Q1 2019 No change 30,000,000 0.2% $29.2M
Q4 2018 No change 9,309,168 2.1% $25.59 $238.2M
Q4 2018 No change 30,000,000 0.3% $30.9M
Q3 2018 No change 9,309,168 2.3% $32.67 $304.1M
Q3 2018 No change 30,000,000 0.3% $34.6M
Q2 2018 No change 9,309,168 1.8% $22.68 $211.1M
Q2 2018 No change 30,000,000 0.3% $30.0M
Q1 2018 No change 9,309,168 2.2% $24.25 $225.7M
Q1 2018 No change 30,000,000 0.3% $30.2M
Q4 2017 No change 9,309,168 2.6% $27.89 $259.6M
Q4 2017 No change 30,000,000 0.3% $33.0M
Q3 2017 No change 9,309,168 4.0% $34.24 $318.7M
Q3 2017 No change 30,000,000 0.5% $37.1M
Q2 2017 No change 9,273,991 4.2% $39.84 $369.5M
Q2 2017 No change 30,000,000 0.5% $40.4M
Q1 2017 No change 9,273,991 4.0% $36.82 $341.5M
Q1 2017 No change 30,000,000 0.4% $37.8M
Q4 2016 Add 26% 9,273,991 3.9% $31.88 $295.7M
Q4 2016 Buy 30,000,000 0.4% $34.1M
Q3 2016 No change 7,350,991 3.8% $36.24 $266.4M
Q2 2016 Add 13% 7,350,991 2.3% $22.69 $166.8M
Q1 2016 Add 1% 6,500,991 1.8% $18.80 $122.2M
Q4 2015 No change 6,420,028 1.9% $16.39 $105.2M
Q3 2015 No change 6,420,028 1.2% $10.99 $70.6M
Q2 2015 Add 1% 6,420,028 1.4% $13.02 $83.6M
Q1 2015 Add 5% 6,366,577 1.9% $17.35 $110.5M
Q4 2014 No change 6,061,228 1.8% $14.92 $90.4M
Q3 2014 No change 6,061,228 2.4% $23.05 $139.7M
Q2 2014 Buy 6,061,228 3.1% $31.88 $193.2M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.